TG THERAPEUTICS INC. - COMMON STOCK

TG Therapeutics to Participate in the 2023 Cantor Global Healthcare Conference

22 9 2023 07:30:00 提供 Nasdaq GlobeNewswire

TG Therapeutics Provides Business Update and Reports Second Quarter 2023 Financial Results

01 8 2023 07:15:00 提供 Nasdaq GlobeNewswire

TG Therapeutics and Neuraxpharm Announce Ex-US Commercialization Agreement for BRIUMVI® (ublituximab-xiiy)

01 8 2023 07:00:01 提供 Nasdaq GlobeNewswire

TG Therapeutics to Host Conference Call on Second Quarter 2023 Financial Results and Business Update

31 7 2023 08:30:00 提供 Nasdaq GlobeNewswire

TG Therapeutics to Participate in the 2023 Jefferies Healthcare Conference

05 6 2023 07:30:00 提供 Nasdaq GlobeNewswire

TG Therapeutics Announces Presentation of Data from the ULTIMATE I & II Phase 3 Trials of BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the 2023 Consortium of Multiple Sclerosis Centers Annual Meeting

02 6 2023 09:15:20 提供 Nasdaq GlobeNewswire

TG Therapeutics Announces European Commission Approval for BRIUMVI® (ublituximab-xiiy) for the Treatment of Relapsing Forms of Multiple Sclerosis in Adults

01 6 2023 09:15:00 提供 Nasdaq GlobeNewswire

TG Therapeutics Announces Data from the ULTIMATE I & II Phase 3 Trials of BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis to be Presented at the 2023 Consortium of Multiple Sclerosis Centers Annual Meeting

31 5 2023 07:30:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

04 5 2023 09:46:02 提供 NetDania Notify

TG Therapeutics to Participate in the Bank of America Securities 2023 Health Care Conference

04 5 2023 07:30:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

03 5 2023 09:59:02 提供 NetDania Notify

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

02 5 2023 09:45:06 提供 NetDania Notify

TG Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results

01 5 2023 07:30:00 提供 Nasdaq GlobeNewswire

TG Therapeutics to Host Conference Call on First Quarter 2023 Financial Results and Business Update

28 4 2023 16:30:00 提供 Nasdaq GlobeNewswire

TG Therapeutics Announces Issuance of Permanent J-Code for BRIUMVI® (ublituximab-xiiy) from Centers for Medicare and Medicaid Services

27 4 2023 07:30:00 提供 Nasdaq GlobeNewswire

TG Therapeutics Announces Presentation of Data from the ULTIMATE I & II Phase 3 Trials of BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 75th Annual Meeting

25 4 2023 08:00:01 提供 Nasdaq GlobeNewswire

TG Therapeutics Announces Positive CHMP Opinion for BRIUMVI™ (ublituximab-xiiy) for the Treatment of Relapsing Forms of Multiple Sclerosis in Adults

31 3 2023 07:30:06 提供 Nasdaq GlobeNewswire

TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of BRIUMVI™ (ublituximab-xiiy) in Multiple Sclerosis to be Presented at the American Academy of Neurology 75th Annual Meeting

03 3 2023 08:30:00 提供 Nasdaq GlobeNewswire

TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2022 Financial Results

28 2 2023 07:30:01 提供 Nasdaq GlobeNewswire

TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2022 Financial Results and Business Update

24 2 2023 07:30:20 提供 Nasdaq GlobeNewswire